Concepedia

Xiaojing Lan

XL

10

Publications

471

Citations

10

H-Index

2014

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Nanjing University of Chinese Medicine

Nanchang University

Xiaojing Lan is an author at Shanghai Institute of Materia Medica specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2014–2024

10

Publications

10

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer

Hanlin Zeng, Jia Qu, Nan Jin et al. · Cancer Cell · 2016 · 163 citations

, , +8

Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

Nan Jin, Aiwei Bi, Xiaojing Lan et al. · Nature Communications · 2019 · 139 citations · Full text

SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors

Xiaomin Wang, Ziqi Chen, Jun Xu et al. · Cell Research · 2022 · 54 citations · Full text

, , +8

Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer

Xiameng Gai, Yingluo Liu, Xiaojing Lan et al. · Cancer Research · 2024 · 24 citations · Full text

Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors

Qiangang Zheng, Shuai Tang, Xian-Lei Fu et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 18 citations · Full text

, , +9

Rows per page

1–5 of 10